글로벌 스포로트리코시스 시장 - 산업 동향 및 2028년까지의 예측

시장 분석 및 통찰력 : 글로벌 스포로트리코시스 시장

스포로트리코시스 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 시장이 4.20%의 CAGR로 성장할 것으로 분석합니다.

스포로트리코시스는 스포로트릭스라는 곰팡이에 의해 발생하는 곰팡이 감염의 한 유형입니다. 주로 토양과 건초, 이끼, 나무 및 장미 덤불과 같은 날카로운 줄기가 있는 식물과 같은 식물체에서 발견됩니다. 식물을 다루는 동안 발생하는 사소한 피부 상처와 긁힘을 통해 전염됩니다. 발열, 기침, 흉통, 통증이 없고 붉은 융기, 호흡 곤란 및 발진이 특징인 피부 감염입니다. 장미 정원사 또는 장미 취급자 질병으로도 알려져 있습니다.

스포로트리코시스 유병률의 증가와 당뇨병 , 만성 폐쇄성 질환, HIV 및 알코올 중독의 증가는 시장 성장률에 영향을 미치는 주요 요인입니다. 또한, 증가하는 의료비 지출, 증가하는 정부 자금 지원 및 질병과 예방 조치에 대한 인식을 확산하기 위한 정부 및 민간 기관의 증가하는 이니셔티브는 스포로트리코시스 시장을 확대할 요인입니다.

2021~2028년 예측 기간 동안 연구 개발 활동과 신흥 시장의 증가는 스포로트리쿰증 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용과 관절염, 뼈 감염, 폐렴 및 뇌 감염과 같은 스포로트리코시스와 관련된 합병증은 시장 성장을 방해하는 요인입니다. 예방 조치에 대한 인식 부족은 앞서 언급한 예측 기간 동안 스포로트리코시스 시장에 더욱 큰 도전이 될 것입니다.

This sporotrichosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sporotrichosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Sporotrichosis Market Scope and Market Size

The sporotrichosis market is segmented on the basis of disease type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of disease type, the sporotrichosis market is segmented into cutaneous sporotrichosis, disseminated sporotrichosis and pulmonary sporotrichosis.
• On the basis of treatment, the sporotrichosis market is segmented into antifungal drugs and others. Antifungal drugs have been further sub-segmented into terbinafine, itraconazole and amphotericin.
• On the basis of diagnosis, the sporotrichosis market is segmented into blood tests, laboratory tests, skin biopsy and others.
• On the basis of dosage, the sporotrichosis market is segmented into tablet, injection and others.
• On the basis of route of administration, the sporotrichosis market is segmented into oral, intravenous and others.
• On the basis of symptoms, the sporotrichosis market is segmented into fever, cough, chest pain, painless bump, shortness of breath and others.
• On the basis of end-users, the sporotrichosis market is segmented into clinic, hospital and others.

The sporotrichosis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Sporotrichosis Market Country Level Analysis

Sporotrichosis market is analyzed and market size information is provided by the country, disease type, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the sporotrichosis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the sporotrichosis market due to major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Sporotrichosis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Sporotrichosis Market Share Analysis

Sporotrichosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global sporotrichosis market research.

스포로트리코시스 시장 보고서에 포함된 주요 기업으로는 Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Sun Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Glenmark Pharmaceuticals Limited, Abbott, Astellas Pharma Inc., Gilead Sciences, Inc., Enzon Pharmaceuticals, Inc., SCYNEXIS, Inc., Merck KGaA, Leadiant Biosciences, Inc., Bausch Health Companies Inc., Beckman Coulter, Inc., Basilea Pharmaceutica Ltd., Agilent Technologies, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66897